NSE filing, NSE: RCDL. Summary written from the filing by ALFA Finder's alert engine.
Rajgor Castor Derivatives Ltd: key numbers
- Share price
- ₹17.00
- Market cap
- ₹81.31 Cr
- Revenue (annual)
- ₹872.2 Cr
- Net profit (annual)
- ₹12.63 Cr
- P/E (TTM)
- 6.4×Sector 38.6×
- Promoter holding
- 55.18%
- FII holding
- 2.29%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rajgor Castor Derivatives Ltd
All →Rajgor Castor Derivatives Other Announcement
Rajgor Castor Derivatives files its integrated governance report for the half year ended September 30, 2026. The routine compliance filing contains no transaction or financial figures.
Rajgor Castor Derivatives Capital Structure Change
Rajgor Castor Derivatives Limited has allotted 23,913,000 equity shares pursuant to its rights issue. The company's paid-up share capital has increased following this allotment.
Rajgor Castor Derivatives Capital Structure Change
Rajgor Castor Derivatives Limited allotted 2.39 crore equity shares on a rights basis at Rs. 10 per share, raising approximately Rs. 23.91 crore.
- Value
- ₹23.91 Cr
Rajgor Castor Derivatives Capacity Expansion: ₹61.5 Cr Investment
Rajgor Castor Derivatives Ltd is expanding manufacturing capacity by 348 MT/day with a ₹61.50 Crore investment, funded by term loans and internal accruals.
- Value
- ₹61.50 Cr
- Execution
- Approx 10 months
- manufacturing capacity
- 348.0 MT per day
Rajgor Castor Derivatives Price Movement Clarification
Rajgor Castor Derivatives Limited clarified to the NSE that the recent movement in its share price is market-driven and not due to undisclosed material information.
Rajgor Castor Derivatives Fund Raise of ₹23.92 Cr
Rajgor Castor Derivatives extended its ₹23.92 Crore rights issue closing date to September 29, 2026. The Rights Issue Committee approved the Second Corrigendum to the Letter of Offer revising the issue timetable.
- Value
- ₹23.92 Cr
Other annual general meeting announcements
All →Unihealth Hospitals Annual General Meeting
Unihealth Hospitals reported postal ballot results: all three resolutions passed, covering a related-party loan-to-equity conversion with UMC Hospitals, variation of unutilised IPO proceeds, and migration from NSE Emerge to the main board. No rupee amount is stated for the approvals.
Vedanta Iron and Steel Annual General Meeting
Vedanta Iron and Steel seeks shareholder approval via postal ballot for seven material related party transaction resolutions. E-voting runs from 29 October to 27 November 2026.
GTPL Hathway Annual General Meeting
GTPL Hathway seeks shareholder approval by postal ballot to appoint Gurjeev Singh Kapoor as Non-Executive Director. E-voting runs November 1 to 30, 2026.
HEG Advanced Materials Annual General Meeting
HEG Advanced Materials seeks approval via postal ballot to appoint seven directors and fix MD Riju Jhunjhunwala's remuneration. E-voting runs October 29 to November 27, 2026.
Trident Texofab Annual General Meeting
Trident Texofab's EGM on 28 October 2026 sought approval for a statutory auditor to fill a casual vacancy. Only one ordinary resolution was tabled.
Sonaselection India Annual General Meeting
Sonaselection India's AGM on 25 Sep 2026 passed all three ordinary resolutions, including adoption of FY2026 audited accounts. Each resolution received 100% of votes polled in favour, with 88.43% of outstanding shares voting.